This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nadine's Most Recent Article

How to Evaluate Biotechs That Aren't Profitable Yet

01/24/02 - 07:50 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >

Other Articles by Nadine

Free Reports

This Earnings Season Could Be a Good One for Biotechs

01/17/02 - 07:27 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
Don't Write Off ImClone Just Yet

01/10/02 - 09:55 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
ImClone's Potential Could Be Worth the Risk

01/03/02 - 08:03 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
Biotech's Prognosis Improves at Year-End

12/27/01 - 07:58 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
The Amgen-Immunex Deal Is the Right Prescription

12/20/01 - 09:24 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
Protein Design Labs Is Still Worth Owning

12/13/01 - 08:34 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
Who Wins, Who Loses in the MedImmune-Aviron Deal

12/06/01 - 08:02 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
How to Play Stem-Cell Research Stocks

11/29/01 - 07:55 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
Some Biotech Mutual Funds Worth Considering

11/21/01 - 07:31 AM EST

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

read more >
Page 1 of 3
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs